SuperworthPrivia Health price to sales ratio PRVA
Market value divided by revenue over the last twelve months, since 2022.
- Today, Oct 23, 2026
- 1.2×
- 5-year median
- 1.6×
- Against its 5-year history
- 7th
- percentile: 0 is its lowest day, 100 its highest
- 5-year range
- 1.1× to 4.1×
- Peer median
- 1.4×
Privia Health's price to sales ratio is 1.2× as of Oct 23, 2026.
That is below its 5-year median of 1.6×, lower than on 93% of days in the last 5 years.
Over that time it ranged from 1.1× in Sep 2026 to 4.1× in Aug 2022.
The median for 10 hospital and care facility stocks of a similar size is 1.4×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 1.2× | 1.1× | 1.5× |
| 2025 | 1.5× | 1.3× | 1.8× |
| 2024 | 1.4× | 1.2× | 1.7× |
| 2023 | 1.7× | 1.6× | 2.5× |
| 2022 | 2.0× | 2.0× | 4.1× |
Against its peers
Companies in Medical - Care Facilities nearest Privia Health's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| PRVAPrivia Health | 1.2× |
| AVAHAveanna Healthcare | 1.1× |
| MDPediatrix Medical | 1.2× |
| ADUSAddus HomeCare | 1.5× |
| PGNYProgyny | 1.7× |
| NHCNational Healthcare | 2.4× |
| OPCHOption Care Health | 0.8× |
| HCSGHealthcare Services | 0.9× |
| ARDTArdent Health | 0.3× |
| LFSTLifeStance Health | 3.1× |
| CONConcentra Group Holdings Parent | 2.2× |
| Peer median | 1.4× |
Where Privia Health ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Privia Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.